banner add

F.D.A.’s Approval of Drug for Autism Upends Review Process

The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.

from NYT > Health https://ift.tt/5WrqwtY
via IFTTT

No comments

Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’

The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the inte...

Theme images by PLAINVIEW. Powered by Blogger.